Over 13 years industry experience in clinical research, leading strategic planning, feasibility, oversight and delivery of global studies and trial portfolios for Phase I, II and III clinical trials across multiple therapeutic areas and treatment modalities.
I advise and collaborate with biotechs and small pharma companies on strategizing their clinical development pipelines, bringing new medicines to the clinic, and ultimately to the patients who need them.
My deep rooted passion for clinical trials originates and has developed from my strong academic background, which has provided me with a solid platform on which to build knowledge, versatility and a holistic approach to strategic planning and management of clinical programmes.
